Search

everythinglearnresearchcommunity

for

Search:↓

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Apremilast may help treat hair loss in alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Cetuximab can cause eyelash growth, which is rare but manageable.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Entospletinib effectively prevents eye and skin GVHD in mice.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Tofacitinib effectively treats Alopecia Areata.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

Adalimumab improved folliculitis decalvans in most patients.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Adalimumab can cause complete hair loss in rare cases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.